Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

Clinical trial NCT04885907 · COMPLETED

Trial details

NCT number: NCT04885907
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Response Impaired Immune Suppression Covid19

Start date: 2021-05-25
Primary completion: 2021-07-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.